Literature DB >> 22297634

IL-12 and IL-23 affect photocarcinogenesis differently.

Christian Jantschitsch1, Michael Weichenthal, Ehrhardt Proksch, Thomas Schwarz, Agatha Schwarz.   

Abstract

Induction of DNA damage by UVR is the key event in photocarcinogenesis. IL-12 and IL-23 are related heterodimeric cytokines consisting of a common p40 unit and a p35/IL-12 and a p19/IL-23 chain, respectively. Both exert immunomodulatory activities but are also found to reduce UVR-induced DNA damage presumably via induction of DNA repair. As both cytokines are also produced in the skin, they may mitigate the risk to develop UVR-induced skin cancer. This appears to be the case as mice lacking p40 were previously shown to be at higher risk for skin tumors upon chronic UVR exposure. As these mice express neither IL-12 nor IL-23, the individual effects of IL-12 or IL-23 could not be evaluated. Thus, mice lacking p35 (IL-12p35-/-) or p19 (IL-23p19-/-) were subjected to chronic UVR exposure. The Kaplan-Meier analysis indicated a significantly increased probability of tumor development in IL-23p19-/- but not in IL-12p35-/- mice. Taken together, in our model, loss of IL-23, but not of IL-12, enhances development of UVR-induced skin tumors, indicating that IL-23 but not IL-12 may counteract photocarcinogenesis. This may have impact on the development of future strategies utilizing antibodies against IL-12 and IL-23, respectively, for the treatment of inflammatory dermatoses.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22297634     DOI: 10.1038/jid.2011.469

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  8 in total

Review 1.  Interleukin (IL)-12 and IL-23 and Their Conflicting Roles in Cancer.

Authors:  Juming Yan; Mark J Smyth; Michele W L Teng
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-07-02       Impact factor: 10.005

Review 2.  Animal models of skin disease for drug discovery.

Authors:  Pinar Avci; Magesh Sadasivam; Asheesh Gupta; Wanessa Cma De Melo; Ying-Ying Huang; Rui Yin; Rakkiyappan Chandran; Raj Kumar; Ayodeji Otufowora; Theodore Nyame; Michael R Hamblin
Journal:  Expert Opin Drug Discov       Date:  2013-01-08       Impact factor: 6.098

3.  Pak1 maintains epidermal stem cells by regulating Langerhans cells and is required for skin carcinogenesis.

Authors:  Kazuhiro Okumura; Megumi Saito; Yasuhiro Yoshizawa; Yuki Ito; Eriko Isogai; Kimi Araki; Yuichi Wakabayashi
Journal:  Oncogene       Date:  2020-05-19       Impact factor: 9.867

4.  IL-23 Inhibits Melanoma Development by Augmenting DNA Repair and Modulating T Cell Subpopulations.

Authors:  Tahseen H Nasti; J Barry Cochran; Raj V Vachhani; Kristopher McKay; Yuko Tsuruta; Mohammad Athar; Laura Timares; Craig A Elmets
Journal:  J Immunol       Date:  2016-12-21       Impact factor: 5.422

5.  Multifaceted contributions of epidermal langerhans cells to cutaneous carcinogenesis.

Authors:  Björn E Clausen; Stephan Grabbe
Journal:  J Invest Dermatol       Date:  2015-05       Impact factor: 8.551

6.  IL-23 and the Tumor Microenvironment.

Authors:  Sweta Subhadarshani; Nabiha Yusuf; Craig A Elmets
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

7.  Solar Simulated Light Induces Cutaneous Squamous Cell Carcinoma in Inbred Mice: A Clinically Relevant Model to Investigate T-Cell Responses.

Authors:  Anngela C Adams; Anne M Macy; Kathylynn Saboda; Sally E Dickinson; David J Glembocki; Denise J Roe; Karen Taraszka Hastings
Journal:  J Invest Dermatol       Date:  2021-07-09       Impact factor: 7.590

Review 8.  Inhibition of interleukin-12 and/or interleukin-23 for the treatment of psoriasis: What is the evidence for an effect on malignancy?

Authors:  Elizabeth N Ergen; Nabiha Yusuf
Journal:  Exp Dermatol       Date:  2018-07       Impact factor: 3.960

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.